Laura S. Mertens
The Netherlands Cancer Institute, Istituto Oncologico Veneto
Papers
12
Total Citations
703
H-Index
6
About
Dr. Laura S. Mertens is a leading urologic oncologist whose research centers on advancing surgical techniques for bladder and prostate cancers, with a particular focus on robot-assisted radical cystectomy (RARC) and intracorporeal neobladder (ICNB) reconstruction. Her most impactful contribution is co-authoring the 2023 European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer, a seminal work cited over 600 times that shapes international clinical practice. Dr. Mertens has pioneered studies on functional outcomes after RARC, reporting on urinary continence and erectile function in males, and has conducted critical cost-analyses comparing robotic and open approaches across Europe. Her work on reducing morbidity after complex procedures, including a 2024 report from the EAU Robotic Urology Section, provides actionable insights for surgeons. She has also explored perioperative blood transfusions' impact on oncological outcomes and temporal trends in urinary diversion, with papers accumulating over 700 citations. Notably, her 2025 investigation into AI-driven segmentation of prostate MRI for 3D-model-guided prostatectomy represents a forward-looking integration of artificial intelligence into surgical planning, underscoring her commitment to innovation. Dr. Mertens’ research directly improves patient outcomes and surgical decision-making, making her a key voice in robotic urology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10